Markku Pasanen
Vieraileva tutkija
Farmasian laitos, Terveystieteiden tiedekunta
markku.pasanen@uef.fi | 040 719 9346
Tutkimusryhmät
Julkaisut
97/97 kappaletta-
Evaluation of Lippia scaberrima Sond. and Aspalathus linearis (Burm.f.) R. Dahlgren extracts on human CYP enzymes and gold nanoparticle synthesis: implications for drug metabolism and cytotoxicity
Kok, Anna-Mari; Juvonen, Risto; Pasanen, Markku; Mandiwana, Vusani; Kalombo, Michel Lonji; Ray, Suprakas Sinha; Rikhotso-Mbungela, Rirhandzu; Lall, Namrita. 2024. BMC complementary medicine and therapies. 24: . 152 -
ICH S1 prospective evaluation study: weight of evidence approach to predict outcome and value of 2-year rat carcinogenicity studies. A report from the regulatory authorities subgroup
Bourcier, Todd; McGovern, Timothy; Cavaliero, Tania; Ebere, Geoffrey; Nishikawa, Akiyoshi; Nishimura, Jihei; Ogawa, Kumiko; Pasanen, Markku; Vespa, Alisa; Van der Laan, Jan Willem. 2024. Frontiers in toxicology. 6: -
Maternal caffeine intake during pregnancy and the risk of delivering a small for gestational age baby: Kuopio Birth Cohort
Kukkonen, Anni; Hantunen, Sari; Voutilainen, Ari; Ruusunen, Anu; Backman, Katri; Kirjavainen, Pirkka V.; Ylilauri, Maija; Voutilainen, Raimo; Pasanen, Markku; Keski-Nisula, Leea. 2024. Archives of gynecology and obstetrics. 310: 359-368 -
Maternal caffeine, coffee and cola drink intake and the risk of gestational diabetes – Kuopio Birth Cohort
Kukkonen, Anni; Hantunen, Sari; Voutilainen, Ari; Ruusunen, Anu; Uusitalo, Lauri; Backman, Katri; Voutilainen, Raimo; Pasanen, Markku; Kirjavainen, Pirkka V; Keski-Nisula, Leea. 2024. Primary care diabetes. 18: 362-367 -
EMA commentary on the ICH guideline for testing for carcinogenicity of pharmaceuticals
van der Laan, Jan Willem; Andersson, Mikael; Beken, Sonja; Bonelli, Milton; Brendler‐Schwaab, Susanne; Kane, Rosemary; Pasanen, Markku; Ponzano, Stefano; Paur, Jakob; Siezen, Christine; Soleng, Anne; Whomsley, Rhys. 2023. British journal of clinical pharmacology. 89: 2341-2348 -
Muisteloita Kuopion Faton tutkimuksesta ja opetuksesta ajalta miekka ja kypärä
Pasanen, Markku. 2023. Publications of the University of Eastern Finland. General series. 44: 69-73 -
Aflatoxin B1 targeted gene expression profiles in human placental primary trophoblast cells
El-Dairi, Rami; Rysä, Jaana; Storvik, Markus; Pasanen, Markku; Huuskonen, Pasi. 2022. Current research in toxicology. 3: -
Longitudinal Analyses of Diet Quality and Maternal Depressive Symptoms During Pregnancy: The Kuopio Birth Cohort Study
Airaksinen, Ville; Ruohomäki, Aleksi; Hantunen, Sari; Keski-Nisula, Leea; Luojus, Maria Katariina; Pekkanen, Juha; Tuomainen, Tomi-Pekka; Heinonen, Seppo; Pasanen, Markku; Lehto, Soili Marianne. 2022. Journal of the academy of nutrition and dietetics. 2023; 123: 77-86.e4 -
The impact of postpartum depressive symptoms on self-reported infant health and analgesic consumption at the age of 12 months: A prospective cohort study
Ruohomäki, Aleksi; Toffol, Elena; Airaksinen, Ville; Backman, Katri; Voutilainen, Raimo; Hantunen, Sari; Tuomainen, Tomi-Pekka; Lampi, Jussi; Kokki, Hannu; Luoma, Ilona; Kumpulainen, Kirsti; Heinonen, Seppo; Keski-Nisula, Leea; Pekkanen, Juha; Pasanen, Markku; Lehto, Soili M.. 2021. Journal of psychiatric research. 136: 388-397 -
Aryl hydrocarbon receptor (AhR) agonist ß-naphthoflavone regulated gene networks in human primary trophoblasts
El Dairi, Rami; Huuskonen, Pasi; Pasanen, Markku; Rysä, Jaana. 2020. Reproductive toxicology. 96: 370-379